Clinical Trial Update: A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 long-term study of HSK44459 tablets in participants with Behçet's disease, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease

Drugs mentioned

• HSK44459 Tablets

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Bechet's Disease | Phase 2 | Status: NOT_YET_RECRUITING